SURA'A Campaign for Stroke Awareness in Primary Health Care Centers (SURA'A)
"Effectiveness of a One-Week Multifaceted SURA'A Consultation-Based Campaign on Stroke Awareness and Intention to Seek Help Among Adults in Primary Health Care Centers
Studieoversikt
Status
Forhold
Intervensjon / Behandling
Detaljert beskrivelse
Studietype
Registrering (Antatt)
Fase
- Ikke aktuelt
Kontakter og plasseringer
Studiekontakt
- Navn: Aya A Ghayadh, Master
- Telefonnummer: +9647822204528
- E-post: ayah.ahmed2106m@conursing.uobaghdad.edu.iq
Studer Kontakt Backup
- Navn: Sadeq A AL-Fayyadh
Deltakelseskriterier
Kvalifikasjonskriterier
Alder som er kvalifisert for studier
- Voksen
- Eldre voksen
Tar imot friske frivillige
Beskrivelse
Inclusion Criteria
Participants will be eligible if they:
Age
- Adults aged ≥18 years residing in Diwaniyah.
- Residence o Living in Diwaniyah communities for at least 6 academic months prior to the study.
Access to Primary Health Centers (PHCs)
- Attending in selected primary health centers where the SURA'A campaign will be implemented.
Cognitive ability
o Able to understand and answer the survey questions in Arabic.
- Consent o Willing to provide informed consent to participate in pre- and post- awareness intervention assessments.
Availability for follow-up
o Agree to participate in both baseline (pre-campaign) and follow-up (post-campaign) assessments.
Exclusion Criteria
Participants will be excluded if they:
- Have a previous confirmed diagnosis of stroke (to avoid bias in baseline awareness).
Severe cognitive impairment
- Have diagnosed dementia, severe mental illness, or cognitive impairment that prevents reliable responses.
Communication barriers
o Cannot communicate in Arabic or has severe hearing/speech impairment that prevents participation.
- Health professionals o Physicians, nurses, paramedics, or students of medical and health colleges (to avoid overestimation of awareness).
Temporary visitors
o Non-residents or individuals visiting Diwaniyah temporarily.
- Refusal or withdrawal o Decline to participate or withdraw at any stage of the study.
Studieplan
Hvordan er studiet utformet?
Designdetaljer
- Primært formål: Forebygging
- Tildeling: Randomisert
- Intervensjonsmodell: Parallell tildeling
- Masking: Ingen (Open Label)
Våpen og intervensjoner
Deltakergruppe / Arm |
Intervensjon / Behandling |
|---|---|
|
Eksperimentell: SURA'A Consultation-Based Campaign Group
This experimental group will participate in a one-week multifaceted SURA'A consultation-based campaign.
The intervention focuses on increasing stroke awareness and the intention to seek medical help among adults in primary health care centers through structured professional consultations and educational materials.
|
The intervention consists of a one-week multifaceted SURA'A consultation-based campaign. This campaign is designed to increase stroke awareness and the intention to seek help among adults attending Primary Health Care Centers. The multifaceted approach likely includes: Targeted Consultations: Providing direct information to participants regarding stroke symptoms and emergency protocols. Educational Outreach: Utilizing the SURA'A framework-which typically focuses on rapid response (Sura'a meaning "speed" in Arabic)-to emphasize the importance of time-sensitive medical intervention. Community Integration: Implementing the campaign within the primary care setting to reach a diverse adult population during their routine health visits. |
|
Ingen inngripen: Routine Health Education Group
Participants in this arm will receive the standard routine health education or conventional care regarding stroke awareness typically provided at the Primary Health Care Centers.
|
Hva måler studien?
Primære resultatmål
Resultatmål |
Tiltaksbeskrivelse |
Tidsramme |
|---|---|---|
|
Stroke Action Test (STAT)
Tidsramme: Baseline (before the campaign) and 1 week later (immediately after the campaign).
|
The Stroke Action Test (STAT) is a validated tool used to assess the participants' knowledge of stroke symptoms and their intended behavioral response (intention to seek help) when witnessing a stroke.
It consists of multiple scenarios or questions.
Scores are calculated based on correct identified actions, with higher scores indicating better knowledge and more appropriate intended response to stroke symptoms.
|
Baseline (before the campaign) and 1 week later (immediately after the campaign).
|
|
action/intention medical help-seeking sub-scale
Tidsramme: Baseline (before the campaign) and 1 week later (immediately after the campaign
|
This sub-scale is a component of the Stroke Action Test (STAT).
It specifically measures the participants' behavioral intentions and their promptness in seeking medical emergency services (e.g., calling an ambulance) when recognizing stroke signs.
It presents various scenarios to evaluate whether the participant would take the correct life-saving action.
|
Baseline (before the campaign) and 1 week later (immediately after the campaign
|
Samarbeidspartnere og etterforskere
Sponsor
Studierekorddatoer
Studer hoveddatoer
Studiestart (Antatt)
Primær fullføring (Antatt)
Studiet fullført (Antatt)
Datoer for studieregistrering
Først innsendt
Først innsendt som oppfylte QC-kriteriene
Først lagt ut (Faktiske)
Oppdateringer av studieposter
Sist oppdatering lagt ut (Faktiske)
Siste oppdatering sendt inn som oppfylte QC-kriteriene
Sist bekreftet
Mer informasjon
Begreper knyttet til denne studien
Ytterligere relevante MeSH-vilkår
Andre studie-ID-numre
- 135 (Registeridentifikator: Research Ethical Approval Committee, College of Nursing , University of Baghdad.)
Plan for individuelle deltakerdata (IPD)
Planlegger du å dele individuelle deltakerdata (IPD)?
Legemiddel- og utstyrsinformasjon, studiedokumenter
Studerer et amerikansk FDA-regulert medikamentprodukt
Studerer et amerikansk FDA-regulert enhetsprodukt
Denne informasjonen ble hentet direkte fra nettstedet clinicaltrials.gov uten noen endringer. Hvis du har noen forespørsler om å endre, fjerne eller oppdatere studiedetaljene dine, vennligst kontakt register@clinicaltrials.gov. Så snart en endring er implementert på clinicaltrials.gov, vil denne også bli oppdatert automatisk på nettstedet vårt. .